TENTH OF RAMADAN FOR PHARMACEUTICAL INDUSTRIES AND DIAGNOSTIC REAGENTS (RAMEDA) S.A.E. Consensus Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Equities
RMDA
EGS381B1C015
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.05 EGP | +3.54% |
|
+0.99% | +24.24% |
Evolution of the average Target Price on Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Price target over the last 5 years
History of analyst recommendation changes
ac3270b8d.COYVg8nricANDEA43c4nDBldQuNR8qVLHTZr6Hr2h34.b9d71ZiCy4JXSyFUu_xXOX4XLrFkpdAEUXEAsEOS6EhpgnHWr5L8hnVFKw~7d4cc6c9bb9206cf6132beb9ddcb361a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.05
EGP
Average target price
3.998
EGP
Spread / Average Target
+95.04%
High Price Target
5.7
EGP
Spread / Highest target
+178.05%
Low Price Target
2.1
EGP
Spread / Lowest Target
+2.44%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMDA Stock
- Consensus Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
